SPC319
Ozanimod eða lyfjafræðilega viðunandi salt þar af, að meðtöldu hýdróklóríðsaltinu
Status:
AfturkölluðApplication date:
17.11.2020Application published:
15.12.2020
Max expiry date:
20.12.2034Medicine name:
ZeposiaMedicine for children:
No
Timeline
Today
17.11.2020Application
15.12.2020Publication
20.12.2034Expires
Marketing license
IS authorization number:
EU/1/20/1442/001 & EU/1/20/1442/002-003Date:
22.6.2020
Foreign authorization number:
EU/1/20/1442Date:
20.5.2020
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3409274